Alterations in Cellular Energy Metabolism Associated with the Antiproliferative Effects of the ATM Inhibitor KU-55933 and with Metformin
Mahvash Zakikhani(McGill University), Michaël Pollak(Jewish General Hospital)
Cited by 37
Related Papers
Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells
|Cancer Research|2006|1k
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
|Endocrine Related Cancer|2008|184
Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells
|Breast Cancer Research|2005|121
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway
|Endocrine Related Cancer|2012|10